Irritable Bowel Syndrome Trial, Recruiting NCT06900491 Sponsor: University Hospital, Rouen Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT06900491
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People whose routine blood test results (including full blood count and inflammation markers) are within normal range
  • People who are enrolled in a French social security scheme
  • People who have read and understood the study information letter and do not object to taking part

Who may not be able to join:

  • People who have been diagnosed with a digestive or bowel condition such as inflammatory bowel disease, microscopic colitis, bowel cancer, or coeliac disease, or who have had major bowel surgery (not including appendix or gallbladder removal)
  • People who do not wish to take part in the study
  • People who do not speak or understand French
  • Women who are pregnant, in labour, or currently breastfeeding
  • People who are in prison or under a court-ordered legal protection measure such as guardianship or curatorship

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02 32 88 82 65

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Rouen
Registry
ClinicalTrials.gov
Start date
4 March 2025
Est. completion
4 September 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Clinical prognostic factors for the disease (use of recreational substances); Clinical prognostic factors for the disease (clinical history); Clinical prognostic factors for the disease (use of treatment); Clinical prognostic factors for the disease (HAD score); Evaluation of validated questionnaires (SCOFF-F questionnaire); Evaluation of validated questionnaires (NIAS questionnaire (ARFID)); Evaluation of validated questionnaires (Francis score); Evaluation of validated questionnaires (GIQLI score); Evaluation of validated questionnaires (Fear of food questionnaire); Evaluation of validated q...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov